Anlotinib Combined with S-1 in the Third-Line Treatment of Stage IV Non-Small Cell Lung Cancer: Study Protocol for Phase II Clinical Trial

por Yang, Xiyue, Xiang, Miao, Geng, Lidan, Wen, Yixue, Du, Xiaobo
Publicado 2019

Efficacy and Safety of Dual Anti-HER2 Blockade and Docetaxel With or Without Carboplatin as Neoadjuvant Regimen for Treatment of HER2-Positive Breast Cancer

por Lin, Binwei, Fan, Jinjia, Liu, Fang, Wen, Yixue, Li, Jie, Gao, Feng, Zhang, Yu, Feng, Gang, Du, Xiaobo, Chen, Wenzhi
Publicado 2023

Prognostic Factors and Models for Elderly (≥70 Years Old) Primary Operable Triple-Negative Breast Cancer: Analysis From the National Cancer Database

por Tang, Zhuowei, Ji, Yuzhu, Min, Yu, Zhang, Xiaohong, Xu, Weiyun, Zhao, Lijuan, Zhang, Jing, Long, Li, Feng, Jing, Wen, Yixue
Publicado 2022

S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma: Study protocol for a randomized controlled ph...

por Wen, Yixue, Zhao, Zhenhuan, Miao, Jidong, Yang, Qilin, Gui, Yan, Sun, Mingqiang, Tian, Honggang, Jia, Qiang, Liao, Dongbiao, Yang, Chen, Du, Xiaobo
Publicado 2017

Anlotinib Combined with S‐1 in Third‐ or Later‐Line Stage IV Non‐Small Cell Lung Cancer Treatment: A Phase II Clinical Trial

por Xiang, Miao, Yang, Xiyue, Ren, Surong, Du, Huan, Geng, Lidan, Yuan, Li, Wen, Yixue, Lin, Binwei, Li, Jie, Zhang, Yu, Feng, Gang, Du, Xiaobo
Publicado 2021

Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicen...

por Li, Jie, Gong, Youling, Diao, Peng, Huang, Qingmei, Wen, Yixue, Lin, Binwei, Cai, Hongwei, Tian, Honggang, He, Bing, Ji, Lanlan, Guo, Ping, Miao, Jidong, Du, Xiaobo
Publicado 2018

Single‐Agent Versus Double‐Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical Trial...

por Zhao, Zhenhuan, Wen, Yixue, Liao, Dongbiao, Miao, Jidong, Gui, Yan, Cai, Hongwei, Chen, Yang, Wei, Min, Jia, Qiang, Tian, Honggang, Sun, Mingqiang, Zhang, Yu, Feng, Gang, Du, Xiaobo
Publicado 2020

Safety and efficacy of pulsed low-dose rate radiotherapy for local recurrent esophageal squamous cell carcinoma after radiotherapy: Study protocol for a prospective multi-center ph...

por Li, Jie, Zhao, Zhenhua, Du, Guobo, Dai, Tangzhi, Zhen, Xuhai, Cai, Hongwei, Liao, Dongbiao, Xiang, Miao, Wen, Yixue, Geng, Lidan, Yang, Xiyue, Feng, Gang, Zhang, Yu, Bai, Jie, Liu, Lei, Du, Xiaobo
Publicado 2019